Aveo CFO Told Investors 'Half The Story,' Jury Hears
The former chief financial officer for Aveo Pharmaceuticals "hid" from investors that a government agency had recommended a new clinical trial for the company's prize kidney cancer drug, an attorney for...To view the full article, register now.
Already a subscriber? Click here to view full article